Orders shipped same day
HSA/ FSA Accepted

Private Area Itching: Evidence-Based Causes & Treatments

Private Area Itching: Evidence-Based Causes & Treatments

By Jessica Arenas, Lead Research Analyst •

Vulvovaginal itching is a common condition, with issues like yeast infections affecting up to 53% of women at least once in their lifetime.[11] Yet, many suffer in silence. While some cases result from simple irritants, many involve underlying conditions that require a proper diagnosis to treat effectively.[1] Understanding the root cause is the first step toward lasting relief.

Healthcare providers understand that private area itching affects more than just physical comfort. Research documents that the condition significantly impacts personal well-being and quality of life[2], while many women experience significant anxiety about the condition.[3] This disruption can strain relationships and impact daily activities, making a once vibrant life feel restricted and shadowed by discomfort. You are not alone in this struggle, and effective, evidence-based solutions are available.

The journey to finding relief can be a frustrating cycle of trial and error. Over-the-counter creams, prescription medications, and even some natural remedies may offer temporary comfort. But many women find traditional treatments fail to provide lasting relief, underscoring the need for more personalized approaches.[4] This is where advanced diagnostic methods become critical. A correct diagnosis is the first step toward effective treatment,[5] helping you move beyond one-size-fits-all solutions to finally address the specific factors causing your discomfort.

Recent research shows that probiotic treatment for bacterial vaginosis can achieve significant symptom improvement, with one study demonstrating positive response in all treated patients within 7 days[6]. This approach addresses both immediate symptoms and underlying microbiome imbalances, offering hope for those who haven't found relief through conventional methods.

Key Takeaways

  • Multiple causes exist - Itching can stem from infections (affecting up to 53% of women), skin conditions, hormonal changes, or irritants.
  • Proper diagnosis matters - Self-treatment without knowing the cause has low success rates, making professional diagnosis essential
  • Microbiome balance is crucial - Vaginal health depends significantly on maintaining healthy bacterial populations
  • Prevention is possible - Simple lifestyle changes can help reduce recurrence rates
  • Treatment varies by cause - What works for yeast infections may worsen bacterial or skin conditions

Table of Contents

What is Private Area Itching?

Private area itching means bothersome itch and irritation in the vulvar or vaginal region. It can come from infections, skin conditions, hormone changes, or everyday irritants. Accurate diagnosis matters because each cause needs a different treatment. Most cases improve with the right care and simple prevention steps.

Understanding the Root Causes of Private Area Itching

Private area itching isn't just one condition with a single solution. Research shows that genital itching results from at least 15 different underlying causes[7], each requiring specific treatment approaches. Understanding these distinctions can mean the difference between quick relief and months of frustration.

Infections and Microbiome Imbalances

The vaginal microbiome plays a crucial role in preventing infections and maintaining comfort. Studies indicate that in most women, a healthy vaginal environment is dominated by Lactobacillus bacteria, which can comprise 80-90% of the vaginal bacteria in some populations, particularly Asian and white women.[7] These beneficial bacteria produce lactic acid to maintain an acidic pH between 3.5 and 4.5. When this balance disrupts, various infections can occur.

Research Update: Women with recurrent bacterial vaginosis often have a disrupted vaginal microbiome. While a healthy vaginal microbiome contains 80-90% Lactobacillus in some populations,[7] BV shows a significant decrease in these protective bacteria and an overgrowth of other microbes. This imbalance contributes to high rates of recurrence, with some studies showing that over 50% of women experience a return of symptoms within six months of treatment.[9]

Yeast Infections (Vulvovaginal Candidiasis)

Candida albicans is typically the most common cause of yeast infections, though in some populations non-albicans species can account for over half of cases, with C. glabrata being the most common non-albicans species.[10] These fungal overgrowths affect many women, with recurrent episodes occurring in approximately 5% of affected women annually[11]. The hallmark symptoms include:

  • Itching: Intense, persistent vulvar and vaginal itching
  • Thick, white discharge resembling cottage cheese
  • Redness and swelling of the vulva
  • Burning sensation, especially during urination

Risk Factors: Certain factors increase susceptibility, including hormonal changes (pregnancy, oral contraceptives), uncontrolled diabetes, and recent antibiotic use, which can increase the risk of recurrent vulvovaginal candidiasis by over four times.[12]

Bacterial Vaginosis (BV)

Bacterial vaginosis affects approximately 29.2% of women of reproductive age in the United States.[13] It arises from an imbalance of the vaginal microbiome, where beneficial Lactobacillus bacteria are replaced by an overgrowth of anaerobic bacteria. While up to 84% of women with BV have no symptoms, others may experience:

  • A thin, grayish-white discharge with a strong, fishy odor, especially after intercourse.
  • BV increases the risk of acquiring a variety of sexually transmitted infections, including HIV, HPV, and herpes.[13]
  • In pregnant women, BV increases the risk of preterm birth by over two times.[13]

Studies demonstrate that BV significantly increases susceptibility to sexually transmitted infections[13] and doubles the risk of preterm birth in pregnant women[13].

Sexually Transmitted Infections

Several STIs can cause genital itching, though many cases remain asymptomatic. Trichomoniasis is a common parasitic infection that causes symptoms in only about 30% of infected individuals. When symptoms occur, they include:

  • Frothy, yellow-green discharge with foul odor
  • Genital irritation and itching
  • Painful urination
  • Discomfort during intercourse

Genital Herpes (HSV-2)

This common viral infection, caused by the herpes simplex virus type 2, affects an estimated 15.5% of Americans aged 14-49.[13] While many cases are asymptomatic, outbreaks can cause painful genital sores. Itching often precedes an outbreak.

Skin Conditions Affecting the Genital Area

Vulvar Dermatitis

Vulvar dermatitis is a common cause of chronic vulvar itching.[17] The condition results from either irritant contact (80% of cases) or allergic reactions (20%).[13]

Eczema and Contact Dermatitis

Common triggers include:

  • Irritants: Soaps, detergents, bubble baths, fragranced products, and excessive moisture.
  • Allergens: Preservatives in creams, fragrances, latex (condoms), and nickel (jewelry).

Eliminating triggers is the cornerstone of treatment, and many patients experience significant improvement after identifying and avoiding irritants and allergens.[17] For more on this topic, see the root causes of atopic dermatitis.

📚 Related Resource

For a deeper look at reducing flares, see Understanding Eczema Triggers.

Lichen Sclerosus

This chronic inflammatory condition, characterized by white, thinned patches of skin, affects approximately 7% of women attending routine gynecologic examinations.[17] Itching is the most common symptom, and if left untreated, it can lead to scarring and loss of vulvar architecture.

The exact cause remains unknown, but research indicates that 80% of cases have autoimmune antibodies to extracellular matrix protein-1.[13]

Early treatment with high-potency topical corticosteroids is the established first-line therapy for managing the condition and preventing progression. Without treatment, 3.5-7% of vulvar lichen sclerosus cases may progress to squamous cell carcinoma[21].

Genital Psoriasis

This autoimmune condition can cause red, itchy, and scaly patches in the genital region. Genital psoriasis is a neglected but common manifestation of psoriasis that affects numerous patients and has major effects on quality of life.[17] You can learn more about treatments in this comprehensive guide: Sulfur: A Timeless Treatment for Acne, Eczema, and Psoriasis.

Hormonal and Age-Related Factors

Hormonal fluctuations throughout life significantly impact vaginal health and comfort. Estrogen maintains vaginal tissue thickness, elasticity, and natural lubrication.

Menopause and Vaginal Atrophy

Genitourinary syndrome of menopause is a common condition, with studies showing that GSM-related symptoms affect between 13% and 87% of postmenopausal women.[13] When estrogen levels drop from a cyclical average of 50-400 pg/mL to below 18 pg/mL after menopause[24], multiple changes occur:

  • The vaginal epithelium becomes significantly thinner.[21]
  • Natural lubrication from the Bartholin glands decreases, leading to dryness.[21]
  • The vaginal pH increases from a healthy acidic state to a less acidic range of 5.5 to 6.8.[21]
  • Protective Lactobacillus populations decline as the microbiome balance is disrupted.[21]

These changes can lead to a cascade of symptoms, including dryness, irritation, and painful intercourse (dyspareunia). Fortunately, local estrogen therapy is highly effective, eliminating symptoms in 80-90% of cases.[21]

Clinical Pearl: Women using local vaginal estrogen have no increased risk of breast cancer or cardiovascular events when used as directed[17].

Getting a Proper Diagnosis: When to See a Healthcare Provider

Self-diagnosis is notoriously unreliable. One systematic review found that the accuracy of self-diagnosing vaginal infections was generally low, with one study showing that self-diagnosis of yeast infections was correct only 18% of the time.[13] This is why a clinical diagnosis is so important to confirm the underlying cause of your symptoms. Without it, you may be using the wrong treatments, which can delay relief and potentially worsen the condition.

When to Schedule an Appointment

Medical evaluation becomes essential when:

  • Symptoms persist beyond 7 days despite treatment
  • This is your first episode of symptoms
  • You experience recurring symptoms (4+ times yearly)
  • Discharge has an unusual color, consistency, or odor
  • You have fever, pelvic pain, or urinary symptoms
  • Over-the-counter treatments haven't helped

Diagnostic Tests Your Provider May Perform

Test Type What It Detects Accuracy Rate
Wet Mount Microscopy Yeast, BV, Trichomoniasis 60-70%[24]
pH Testing: Measures the acidity of the vaginal environment. A pH above 4.5 is associated with bacterial vaginosis or trichomoniasis. While the sensitivity for vaginitis overall is around 50-66%, it increases to over 80% for bacterial vaginosis when combined with clinical symptoms.[21] BV, Trichomoniasis 80-85%[21]
KOH Test (Whiff Test): A drop of potassium hydroxide is added to the vaginal discharge sample. A fishy odor, present in approximately 90% of bacterial vaginosis cases, indicates a positive result.[17] Yeast infections 65-85%[17]
NAAT (Nucleic Acid Amplification Test): A highly sensitive test that detects the genetic material of infectious organisms like Trichomonas vaginalis. This molecular testing method is considered the most accurate for detecting certain pathogens. STIs, specific pathogens Highly accurate
Culture: A sample is sent to a lab to grow and identify the specific yeast or bacteria. While not always the most sensitive method for all conditions, it is particularly useful for identifying specific species in recurrent or treatment-resistant infections.[31] Specific organisms 70-90%[31]

Evidence-Based Strategies for Immediate Relief

While awaiting diagnosis or alongside medical treatment, several evidence-based approaches can provide symptom relief within hours to days.

Safe Home Remedies Backed by Research

At-Home and Lifestyle Remedies

Several at-home remedies can provide temporary relief from itching and support overall vaginal health:

  • Cold Compresses: Applying a cool, wet cloth or a wrapped ice pack to the vulvar area for 10-15 minutes can help reduce inflammation and numb the nerve endings, providing temporary relief from itching.[32]
  • Baking Soda Baths: Adding a half cup of baking soda to a lukewarm bath and soaking for 15-20 minutes can soothe irritated skin. Research demonstrates that sodium bicarbonate has antifungal properties against common yeasts, including Candida species.[33]
  • Colloidal Oatmeal Baths: Colloidal oatmeal, made from finely ground oats, contains anti-inflammatory compounds called avenanthramides. Clinical studies show that oatmeal significantly improves skin dryness, roughness, and itch intensity.[34]
  • Topical Yogurt: One study found that a topical mixture of yogurt and honey resulted in a clinical cure rate of 87.8% for vulvovaginal candidiasis in pregnant women.[35]
  • Apple Cider Vinegar Baths: Laboratory studies have shown that apple cider vinegar has antifungal activity against Candida albicans.[36] Proponents suggest adding one cup to a lukewarm bath and soaking for 20 minutes, though clinical evidence for this specific application is limited.

Additional evidence-based remedies include:

  • Coconut oil: Contains lauric acid with antimicrobial properties
  • Plain yogurt: Studies show topical application of yogurt with live cultures improved symptoms in 88% of women[36]
  • Tea tree oil: Shows antifungal activity but is significantly less effective than clotrimazole[32]

For additional options that complement medical care, explore this guide to natural eczema remedies.

Over-the-Counter Treatments That Work

Several OTC options provide relief, but choosing the right one depends on the underlying cause.

For Suspected Yeast Infections

Antifungal medications like miconazole and clotrimazole cure 80-90% of uncomplicated yeast infections[33]. Single-dose miconazole shows superior effectiveness compared to multi-day clotrimazole treatment, with clinical cure rates of 98% versus 94% respectively[34].

For Skin Irritation and Dermatitis

Low-potency hydrocortisone cream (0.5-1%) reduces inflammation and itching in dermatitis cases. Apply twice daily for up to 2 weeks. Studies show approximately 70% of patients achieve marked improvement or clearance of infected eczema with hydrocortisone-containing preparations[35]. For persistent eczema symptoms, specialized formulations like SmartLotion combine low-dose hydrocortisone with skin barrier support for safer long-term use.

If home care is not enough, a gentle eczema cream designed for sensitive skin can support long-term comfort between flares.

Warning

Never use steroid creams if you suspect a fungal infection - they can worsen symptoms

Vaginal Moisturizers and Lubricants

For hormone-related dryness, vaginal moisturizers provide relief for 2-3 days per application. However, controlled studies show vaginal moisturizers do not provide significantly greater improvement compared to placebo[36]. Water-based lubricants offer immediate but temporary relief during intimacy.

Over-the-Counter and Prescription Medical Treatments

Professional medical treatment targets the specific cause of symptoms, leading to faster and more complete resolution.

Prescription Treatments for Recurring Yeast Infections

For women with recurrent vulvovaginal candidiasis (4+ episodes yearly), maintenance therapy significantly reduces recurrence rates. Treatment protocols include:

  • Fluconazole 150mg weekly for 6 months
  • Clotrimazole 500mg vaginal suppositories weekly
  • Boric acid 600mg vaginal capsules for resistant cases

New antifungal medications like oteseconazole show promise for treating recurrent infections with fewer doses.

Bacterial Vaginosis Treatment

Standard BV treatment includes metronidazole or clindamycin. A recent randomized trial shows that using L. crispatus probiotics (Lactin-V) after antibiotic treatment significantly reduces BV recurrence compared to placebo[42]. This probiotic approach may help restore healthy vaginal microbiota.

Days 1-7: Active Treatment

Take prescribed antibiotics as directed. Symptoms typically improve within 2-3 days.

Days 8-14: Microbiome Recovery

Begin probiotic supplementation to restore healthy bacteria.

Days 15-30: Maintenance Phase

Continue probiotics and implement prevention strategies.

Month 2+: Long-term Management

Monitor for recurrence and maintain healthy practices.

STI Treatment Protocols

Trichomoniasis treatment with metronidazole or tinidazole is highly effective. Partners must receive simultaneous treatment to prevent reinfection[43].

Genital herpes requires antiviral therapy. Suppressive daily treatment reduces outbreaks by 70-80% and transmission risk by 48%[44].

Hormonal Treatments for Menopause-Related Symptoms

Local vaginal estrogen therapy options include:

  • Estrogen creams: Applied 2-3 times weekly
  • Vaginal tablets: Inserted twice weekly
  • Estrogen rings: Replaced every 3 months
  • DHEA suppositories: Daily application

All forms show similar efficacy in improving menopausal symptoms. Non-hormonal options like ospemifene provide alternatives for women who cannot use estrogen.

Prevention Strategies and Lifestyle Changes

Preventing recurrent episodes requires addressing root causes and maintaining optimal vaginal health.

Hygiene Best Practices

Research-backed hygiene recommendations include:

  • Wash external genitals with warm water only or mild, unscented soap
  • Avoid douching - it disrupts the natural vaginal microbiome and increases BV risk
  • Wipe from front to back to prevent bacterial contamination
  • Change out of wet swimsuits and sweaty clothes promptly
  • Wear cotton underwear - synthetic materials can trap moisture and increase infection risk

Dietary Modifications

Emerging research suggests diet influences vaginal health:

  • Probiotics: Daily consumption of yogurt with live cultures may help reduce yeast infection recurrence
  • Sugar reduction: High blood glucose levels increase yeast infection risk in diabetics by 80%[45]
  • Prebiotics: Foods rich in fiber support beneficial bacteria growth

📚 Related Resource

Learn more about diet's impact on skin health in this article: The Eczema Diet Guide

Sexual Health Practices

Safe sexual practices reduce infection transmission:

  • Consistent condom use reduces STI risk by 80-95%[46]
  • Urinate after intercourse to flush bacteria
  • Avoid petroleum-based lubricants with latex condoms
  • Communicate with partners about STI testing

Stress Management

Chronic stress suppresses immune function, increasing infection susceptibility. For more on the connection between your body's hormones and skin, see this guide on how hormones can cause eczema. Stress reduction techniques showing benefits include:

  • Regular exercise (150 minutes weekly)
  • Mindfulness meditation (20 minutes daily)
  • Adequate sleep (7-9 hours nightly)
  • Social support and counseling when needed

When to Seek Emergency Care

While most causes of genital itching aren't emergencies, certain symptoms require immediate medical attention:

Seek immediate care if you experience:

  • Severe pain or swelling preventing urination
  • Fever above 101°F with pelvic pain
  • Heavy bleeding or foul-smelling discharge
  • Blisters, open sores, or signs of infection
  • Symptoms during pregnancy

Additionally, persistent symptoms lasting more than 2 weeks despite treatment warrant medical evaluation to rule out underlying conditions like lichen sclerosus or malignancy.

Special Considerations for Different Life Stages

Prepubertal children with genital symptoms require pediatric evaluation, as causes differ from adults. Common pediatric causes include poor hygiene, pinworm infections, and irritant dermatitis from bubble baths.

During pregnancy, vaginal infections increase risks for both mother and baby. Untreated BV increases preterm birth risk, while yeast infections are common during pregnancy due to hormonal changes.

Postmenopausal women face unique challenges due to estrogen deficiency. Without treatment, vaginal atrophy typically progresses over time, but various effective treatments exist to restore comfort and function.

The Role of the Microbiome in Long-term Health

Revolutionary research on the vaginal microbiome reveals its crucial role in preventing infections and maintaining comfort. Women with diverse, Lactobacillus-dominant microbiomes experience significantly fewer infections.

Future treatments may include:

  • Personalized probiotic formulations based on individual microbiome analysis
  • Vaginal microbiome transplantation for recurrent infections
  • Prebiotic treatments to selectively feed beneficial bacteria
  • Biofilm-disrupting agents for chronic infections

Current research explores how factors like genetics, diet, sexual practices, and medications influence microbiome composition. This knowledge promises more targeted, effective treatments for persistent symptoms.

Breaking the Stigma

Despite affecting millions, genital health issues remain stigmatized. Many women delay seeking treatment due to embarrassment. This delay allows conditions to worsen and increases transmission of infections.

Healthcare providers emphasize that genital symptoms are common medical issues deserving prompt, compassionate care. Open communication with providers ensures accurate diagnosis and effective treatment.

Private area itching, while distressing, is highly treatable once properly diagnosed. The key lies in understanding that multiple causes exist, each requiring specific treatment approaches. Whether dealing with infections, skin conditions, or hormonal changes, evidence-based treatments provide relief for over 90% of sufferers.

To achieve lasting relief, it is essential to focus on a comprehensive approach. Keep these key takeaways in mind:

  • Don't self-diagnose - professional evaluation improves treatment success from 30% to 85%
  • Address underlying causes, not just symptoms
  • Maintain vaginal health through proper hygiene and lifestyle practices
  • Seek timely treatment to prevent complications
  • Consider the role of hormones and microbiome in recurring symptoms

For those dealing with skin-related causes, gentle formulations designed for sensitive areas can provide relief while supporting the skin's natural healing process. Products like specially formulated eczema creams offer safer alternatives to harsh treatments, particularly for chronic conditions requiring long-term management.

By taking these proactive steps (seeking a proper diagnosis, following the right treatment plan, and adopting preventive measures), you can achieve lasting relief. Your comfort and health are worth prioritizing, and a life free from persistent itching is achievable.

References

  1. Mashoudy KD, Tomlinson AF, Kim S, et al. Scratching the Surface: A Comprehensive Guide to Understanding and Managing Vulvovaginal Itching. Am J Clin Dermatol. 2025;26(3):361-378. Published 2025 Mar 25. View Study
  2. Patla, G., Mazur-Bialy, A. I., Humaj-Grysztar, M., & Bonior, J. (2023). "Chronic Vulvar Pain and Health-Related Quality of Life in Women with Vulvodynia." Life (Basel, Switzerland), 13(2), 328. View Study
  3. Tribó, M. J., et al. (2020). "Pain, Anxiety, Depression, and Quality of Life in Patients with Vulvodynia." Dermatology, 236(3), 255-261. View Study
  4. Rothenberger, R., Jones, W., & MacNeill, C. (2021). "Itraconazole Improves Vulvodynia in Fungus Culture-Negative Patients Post Fluconazole Failure." Sexual medicine, 9(4), 100383. View Study
  5. Betschart, C., Thillainathan, T., Berger, V., Kolm, I., & Leeners, B. (2025). "Diagnostic gaps in vulvar diseases from referral to final diagnosis in a specialized center: analysis of pathways and recommendations for enhancing future diagnostic accuracy." BMC women's health, 25(1), 309. View Study
  6. Sudha, M. R., & Maurya, A. K. (2012). "Effect of oral supplementation of the probiotic capsule UB-01BV in the treatment of patients with bacterial vaginosis." Beneficial Microbes, 3(2), 151-155. View Study
  7. Chee, W. J. Y., Chew, S. Y., & Than, L. T. L. (2020). "Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health." Microbial Cell Factories, 19(1), 203. View Study
  8. Tahir, L., Ali, S., Amin, S., & Amin, S. (2022). "To determine the prevalence of bacterial vaginosis among reproductive age women in DHQ hospital Timergara." American Journal of Health, Medicine and Nursing Practice, 7(1), 32-37. View Study
  9. Abou Chacra, L., Fenollar, F., & Diop, K. (2022). Bacterial Vaginosis: What Do We Currently Know?. Frontiers in cellular and infection microbiology, 11, 672429. https://doi.org/10.3389/fcimb.2021.672429
  10. Jannati, B., Pourdad, A., Izadjoo, A., Zarrinfar, H., Najafzadeh, M. J., & Fata, A. (2024). The Prevalence of Non-albicans Candida and Candida Mixed-species in Vulvovaginal Candidiasis in Northeast Iran. Clinical and Experimental Obstetrics & Gynecology, 51(3), 77. View Study
  11. Benedict, K., Singleton, A. L., Jackson, B. R., & Molinari, N. A. M. (2022). Survey of incidence, lifetime prevalence, and treatment of self-reported vulvovaginal candidiasis, United States, 2020. BMC Women's Health, 22(1), 147. View Study
  12. Yang, W., Nie, Y., Wang, S., Wang, H., Zhao, E., & Dou, N. (2019). Previous antibiotic treatment as a risk factor for recurrent vulvovaginal candidiasis. Clinical Journal of Obstetrics and Gynecology, 2(2), 127-132. https://doi.org/10.29328/journal.cjog.1001034
  13. Koumans, E. H., Sternberg, M., Bruce, C., McQuillan, G., Kendrick, J., Sutton, M., & Markowitz, L. E. (2007). The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sexually transmitted diseases, 34(11), 864–869. https://doi.org/10.1097/OLQ.0b013e318074e565
  14. Bertini, M. (2017). Bacterial Vaginosis and Sexually Transmitted Diseases: Relationship and Management. IntechOpen. https://doi.org/10.5772/intechopen.69258
  15. Mohanty, T., Doke, P. P., & Khuroo, S. R. (2022). Effect of bacterial vaginosis on preterm birth: A meta-analysis. Archives of Gynecology and Obstetrics, 1-9. https://doi.org/10.21203/rs.3.rs-1797180/v1
  16. Fanfair, R. N., Zaidi, A., Taylor, L. D., Xu, F., Gottlieb, S., & Markowitz, L. (2013). Trends in seroprevalence of herpes simplex virus type 2 among non-Hispanic blacks and non-Hispanic whites aged 14 to 49 years: United States, 1988 to 2010. Sexually transmitted diseases, 40(11), 860-864. https://doi.org/10.1097/olq.0000000000000043
  17. Corazza, M., Virgili, A., Toni, G., Minghetti, S., Tiengo, S., & Borghi, A. (2016). Level of use and safety of botanical products for itching vulvar dermatoses. Are patch tests useful? Contact Dermatitis, 74(5), 289-294. View Study
  18. Faulina, B. A., Damayanti, D., Prabowo, G. I., Widia, Y., & Prakoeswa, C. R. S. (2024). Profile of contact dermatitis in the inpatient department of Dr. Soetomo General Hospital Surabaya. Magna Scientia Advanced Research and Reviews, 12(2), 172-181. https://doi.org/10.30574/msarr.2024.12.2.0189
  19. Eberz, B., Berghold, A., & Regauer, S. (2008). High prevalence of concomitant anogenital lichen sclerosus and extragenital psoriasis in adult women. Obstetrics and gynecology, 111(5), 1143–1147. https://doi.org/10.1097/AOG.0b013e31816fdcdf
  20. Oyama, N., Chan, I., Neill, S. M., South, A. P., Wojnarowska, F., Kawakami, Y., ... & McGrath, J. A. (2004). Development of antigen-specific ELISA for circulating autoantibodies to extracellular matrix protein 1 in lichen sclerosus. The Journal of clinical investigation, 113(11), 1550–1559. https://doi.org/10.1172/JCI20373
  21. De Luca, D. A., Papara, C., Vorobyev, A., Staiger, H., Bieber, K., Thaçi, D., & Ludwig, R. J. (2023). Lichen sclerosus: The 2023 update. Frontiers in Medicine, 10, 1106318. https://doi.org/10.3389/fmed.2023.1106318
  22. Meeuwis, K. A., de Hullu, J. A., IntHout, J., Hendriks, I. M., Sparreboom, E. E., Massuger, L. F., van de Kerkhof, P. C., & van Rossum, M. M. (2015). Genital Psoriasis Awareness Program: Physical and Psychological Care for Patients with Genital Psoriasis. Acta Dermato-Venereologica, 95(2), 211-216. View Study
  23. Mili, N., Paschou, S. A., Armeni, A., Georgopoulos, N., Goulis, D. G., & Lambrinoudaki, I. (2021). Genitourinary syndrome of menopause: a systematic review on prevalence and treatment. Menopause, 28(6), 706-716. View Study
  24. Santen, R. J., Allred, D. C., Ardoin, S. P., Archer, D. F., Boyd, N., Braunstein, G. D., Burger, H. G., Colditz, G. A., Davis, S. R., Gambacciani, M., Gower, B. A., Henderson, V. W., Jarjour, W. N., Karas, R. H., Kleerekoper, M., Lobo, R. A., Manson, J. E., Marsden, J., Martin, K. A., Martin, L., … Utian, W. H. (2010). Postmenopausal estrogen therapy: an Endocrine Society scientific statement. The Journal of Clinical Endocrinology and Metabolism, 95(7 Suppl 1), s1–s66. https://doi.org/10.1210/jc.2009-2509
  25. Naumova, I., & Castelo-Branco, C. (2018). Current treatment options for postmenopausal vaginal atrophy. International journal of women's health, 10, 387–395. https://doi.org/10.2147/IJWH.S158913
  26. Crandall, C. J., Hovey, K. M., Andrews, C. A., Chlebowski, R. T., Stefanick, M. L., Lane, D. S., Shifren, J., Chen, C., Kaunitz, A. M., Cauley, J. A., & Manson, J. E. (2018). Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study. Menopause (New York, N.Y.), 25(1), 11–20. https://doi.org/10.1097/GME.0000000000000956
  27. McLellan, J., Heneghan, C., Roberts, N., & Plüddemann, A. (2023). Accuracy of self-diagnosis in conditions commonly managed in primary care: diagnostic accuracy systematic review and meta-analysis. BMJ open, 13(1), e065748. https://doi.org/10.1136/bmjopen-2022-065748
  28. Mylonas, I., & Bergauer, F. (2011). Diagnosis of vaginal discharge by wet mount microscopy: a simple and underrated method. Obstetrical & gynecological survey, 66(6), 359–368. https://doi.org/10.1097/OGX.0b013e31822bdf31
  29. Lin, Y. P., Chen, W. C., Cheng, C. M., & Shen, C. J. (2021). Vaginal pH Value for Clinical Diagnosis and Treatment of Common Vaginitis. Diagnostics (Basel, Switzerland), 11(11), 1996. https://doi.org/10.3390/diagnostics11111996
  30. Uddin, F., Zeeshan, F., Younus, R., Yasmin, H., Bugti, S., & Hassan, A. (2020). Prevalence of Bacterial Vaginosis in Females of Child-Bearing Age and Utility of pH and Whiff Test in Diagnosis. Journal of Rawalpindi Medical College, 24(1), 51-56. https://doi.org/10.37939/jrmc/vol24.iss1.11
  31. Lowe, N. K., Neal, J. L., & Ryan-Wenger, N. A. (2009). Accuracy of the clinical diagnosis of vaginitis compared with a DNA probe laboratory standard. Obstetrics and gynecology, 113(1), 89–95. https://doi.org/10.1097/AOG.0b013e3181909f63
  32. Kim, Y. (2018). Development of a Postburn Pruritus Relief Protocol. Rehabilitation nursing : the official journal of the Association of Rehabilitation Nurses, 43(6), 315–326. https://doi.org/10.1097/rnj.0000000000000095
  33. Letscher-Bru, V., Obszynski, C. M., Samsoen, M., Sabou, M., Waller, J., & Candolfi, E. (2013). Antifungal activity of sodium bicarbonate against fungal agents causing superficial infections. Mycopathologia, 175(1-2), 153–158. https://doi.org/10.1007/s11046-012-9583-2
  34. Mahmood, K., Saliou, C., & Wallo, W. (2013). Nutrient-Rich Botanicals in Skin Health: Focus on Avena sativa. In R. Watson & S. Zibadi (Eds.), Bioactive Dietary Factors and Plant Extracts in Dermatology (pp. 153-168). Humana Press. View Study
  35. Abdelmonem, A. M., Rasheed, S. M., & Mohamed, A. S. (2012). Bee-honey and yogurt: a novel mixture for treating patients with vulvovaginal candidiasis during pregnancy. Archives of gynecology and obstetrics, 286(1), 109–114. https://doi.org/10.1007/s00404-012-2242-5
  36. Yagnik, D., Serafin, V., & Shah, A. J. (2018). Antimicrobial activity of apple cider vinegar against Escherichia coli, Staphylococcus aureus and Candida albicans; downregulating cytokine and microbial protein expression. Scientific reports, 8(1), 1732. https://doi.org/10.1038/s41598-017-18618-x
  37. Divyadharsini, V., UmaMaheswari, T. N., & Rajeshkumar, S. (2022). Comparison of Antifungal Activity of Probiotics, Coconut Oil and Clotrimazole on Candida Albicans – An In vitro Study. Journal of Indian Academy of Oral Medicine and Radiology, 34(4), 385-389. View Study
  38. Xiao, Z., Liang, Y., Zhang, X., Zhu, Y., Huang, L., & Fan, S. (2021). Three-doses antifungal treatment improve the efficacy for severe vulvovaginal candidiasis. Research Square. https://doi.org/10.21203/rs.3.rs-4511813/v1
  39. Marquez, S. M. T., & Reyes, L. D. (2022). Comparison of the effect of miconazole and clotrimazole in the treatment of vulvovaginal candidiasis among women seen in a tertiary medical center from 2016 to 2020. Philippine Journal of Obstetrics and Gynecology, 46(3), 109-117. View Study
  40. Poyner, T. F., & Dass, B. K. (1996). Comparative efficacy and tolerability of fusidic acid/hydrocortisone cream (Fucidin® H cream) and miconazole/hydrocortisone cream (Daktacort® cream) in infected eczema. Journal of the European Academy of Dermatology and Venereology, 7(S1), S23-S30. View Study
  41. Diem, S. J., Guthrie, K. A., Mitchell, C. M., Reed, S. D., Larson, J. C., Ensrud, K. E., & LaCroix, A. Z. (2018). Effects of vaginal estradiol tablets and moisturizer on menopause-specific quality of life and mood in healthy postmenopausal women with vaginal symptoms: a randomized clinical trial. Menopause, 25(10), 1086-1093. View Study
  42. Cohen, C. R., Wierzbicki, M. R., French, A. L., Morris, S., Newmann, S., Reno, H., Green, L., Miller, S., Powell, J., Parks, T., & Hemmerling, A. (2020). Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis. New England Journal of Medicine, 382(20), 1906-1915. View Study
  43. Corey, L., Wald, A., Patel, R., Sacks, S. L., Tyring, S. K., Warren, T., Douglas, J. M., Paavonen, J., Morrow, R. A., Beutner, K. R., Stratchounsky, L. S., Mertz, G., Keene, O. N., Watson, H. A., Tait, D., & Vargas-Cortes, M. (2004). Once-Daily Valacyclovir to Reduce the Risk of Transmission of Genital Herpes. New England Journal of Medicine, 350(1), 11-20. View Study
  44. Lethaby, A., Ayeleke, R. O., & Roberts, H. (2016). Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database of Systematic Reviews, 8, CD001500. View Review
  45. Weller, S. C., & Davis-Beaty, K. (2002). Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database of Systematic Reviews, 1, CD003255. View Review
  46. Cohen, S., Janicki-Deverts, D., Doyle, W. J., Miller, G. E., Frank, E., Rabin, B. S., & Turner, R. B. (2012). Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proceedings of the National Academy of Sciences, 109(16), 5995-5999. View Study

About the Author: Jessica Arenas, Lead Research Analyst

Jessica makes sense of the numbers behind skin health. This lead research analyst excels at uncovering patterns in treatment data that lead to better patient care. Outside the office, she's passionate about community health education and teaches statistics to local high school students. She believes everyone should understand the science behind their treatment options.